• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利东北部利用行政健康数据建立肾脏替代治疗登记系统的初始情况与效用

Inception and utility of a renal replacement registry using administrative health data in North-East Italy.

作者信息

Valent Francesca, Busolin Anna, Boscutti Giuliano

机构信息

Servizio Epidemiologia e Flussi Informativi-Direzione Centrale Salute, Integrazione Sociosanitaria, Politiche Sociali e Famiglia-Regione Autonoma Friuli Venezia Giulia, Udine, Italy.

Struttura Complessa di Nefrologia e Dialisi-Azienda Sanitaria Universitaria Integrata di Trieste, Trieste, Italy.

出版信息

J Ren Care. 2017 Jun;43(2):121-127. doi: 10.1111/jorc.12192. Epub 2017 Jan 18.

DOI:10.1111/jorc.12192
PMID:28097800
Abstract

BACKGROUND

Disease registries are useful tools for public health planning, evaluating clinical practice and providing information on cohorts of patients.

METHODS

The administrative databases of the regional health information system of Friuli Venezia Giulia, Italy were used to build a regional registry of the resident population in renal replacement therapy (including dialysis and renal transplantation), through an algorithm taking into account hospital discharge and outpatient ambulatory care data. The registry includes an anonymous univocal identifier, the start date for the replacement therapy and changes of status (haemodialysis, peritoneal dialysis, renal transplantation). Data from the registry were used to estimate incidence rate, prevalence and mortality of patients receiving renal replacement therapy in 2014. In addition, we described an example of how the registry can be used to assess the prevalence of selected comorbidities.

RESULTS

In Friuli Venezia Giulia in 2014, we estimated an incidence rate of renal replacement therapy of 166 per million inhabitants and a prevalence of 1,400 per million inhabitants. A total of 10% of the patients died in the study year. Hypertension, heart disease and diabetes mellitus were common co-morbidities.

CONCLUSION

The registry allows us to estimate the incidence rate and prevalence of renal replacement therapy and also to investigate specific issues regarding these patients through record linkage with other administrative health databases.

摘要

背景

疾病登记是公共卫生规划、评估临床实践以及提供患者队列信息的有用工具。

方法

利用意大利弗留利-威尼斯朱利亚地区卫生信息系统的行政数据库,通过一种考虑医院出院和门诊流动护理数据的算法,建立了一个肾脏替代治疗(包括透析和肾移植)常住人口的区域登记册。该登记册包括一个匿名的唯一标识符、替代治疗的开始日期以及状态变化(血液透析、腹膜透析、肾移植)。登记册中的数据用于估计2014年接受肾脏替代治疗患者的发病率、患病率和死亡率。此外,我们描述了一个如何利用该登记册评估选定合并症患病率的示例。

结果

2014年在弗留利-威尼斯朱利亚,我们估计肾脏替代治疗的发病率为每百万居民166例,患病率为每百万居民1400例。在研究年度,共有10%的患者死亡。高血压、心脏病和糖尿病是常见的合并症。

结论

该登记册使我们能够估计肾脏替代治疗的发病率和患病率,并通过与其他行政卫生数据库的记录链接来调查有关这些患者的具体问题。

相似文献

1
Inception and utility of a renal replacement registry using administrative health data in North-East Italy.意大利东北部利用行政健康数据建立肾脏替代治疗登记系统的初始情况与效用
J Ren Care. 2017 Jun;43(2):121-127. doi: 10.1111/jorc.12192. Epub 2017 Jan 18.
2
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处:2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.
3
[REIN Report 2011--summary].[2011年肾脏疾病改善全球结果(KDIGO)报告——摘要]
Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.
4
Value of the Rare Disease Registry of the Italian Region Friuli Venezia Giulia.意大利弗留利-威尼斯朱利亚大区罕见病登记处的价值。
Value Health. 2019 Sep;22(9):1003-1011. doi: 10.1016/j.jval.2019.04.1917. Epub 2019 May 24.
5
[Reliability of administrative databases in epidemiological research: the example of end-stage renal disease requiring renal replacement therapy in patients with diabetes].[行政数据库在流行病学研究中的可靠性:以糖尿病患者中需要肾脏替代治疗的终末期肾病为例]
G Ital Nefrol. 2009 Mar-Apr;26 Suppl 45:S7-11.
6
UK Renal Registry 11th Annual Report (December 2008): Chapter 6 Comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland: national and centre-specific analyses.英国肾脏注册处第11次年度报告(2008年12月):第6章 英格兰、威尔士和北爱尔兰开始接受肾脏替代治疗患者的合并症及当前吸烟状况:全国及特定中心分析
Nephron Clin Pract. 2009;111 Suppl 1:c97-111. doi: 10.1159/000209995. Epub 2009 Mar 26.
7
Present and future of kidney replacement therapy in Italy: the perspective from Italian Dialysis and Transplantation Registry (IDTR).意大利肾脏替代治疗的现状与未来:来自意大利透析与移植注册中心(IDTR)的观点。
J Nephrol. 2020 Dec;33(6):1195-1200. doi: 10.1007/s40620-020-00750-z. Epub 2020 May 22.
8
UK Renal Registry 13th Annual Report (December 2010): Chapter 4: comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2008 to 2009.英国肾脏登记册第 13 次年度报告(2010 年 12 月):第 4 章:2008 至 2009 年期间在英格兰、威尔士和北爱尔兰开始肾脏替代治疗的患者的合并症和当前吸烟状况。
Nephron Clin Pract. 2011;119 Suppl 2:c85-96. doi: 10.1159/000331754. Epub 2011 Aug 26.
9
Renal replacement therapy in Brunei Darussalam: comparing standards with international renal registries.文莱达鲁萨兰国的肾脏替代治疗:与国际肾脏登记处比较标准
Nephrology (Carlton). 2014 May;19(5):288-95. doi: 10.1111/nep.12228.
10
[Using Dialysis and Transplantation Registries for regional and small-area epidemiology].[利用透析和移植登记处开展区域及小范围流行病学研究]
G Ital Nefrol. 2003 Mar-Apr;20(2):151-9.

引用本文的文献

1
Development of minimum data set and electronic registry for hemodialysis patients management.用于血液透析患者管理的最小数据集和电子登记系统的开发。
BMC Med Inform Decis Mak. 2025 Feb 10;25(1):69. doi: 10.1186/s12911-025-02914-y.
2
Kidney Replacement Treatment in South-Western Italy (Campania): Population-Based Study on Gender and Residence Inequalities in Health Care Access.意大利西南部(坎帕尼亚)的肾脏替代治疗:基于人群的医疗保健获取方面的性别和居住不平等研究。
J Clin Med. 2021 Jan 24;10(3):449. doi: 10.3390/jcm10030449.
3
Developing and validating an algorithm to identify incident chronic dialysis patients using administrative data.
开发和验证一种使用行政数据识别新发生慢性透析患者的算法。
BMC Med Inform Decis Mak. 2020 Aug 11;20(1):185. doi: 10.1186/s12911-020-01206-x.
4
Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: Usefulness of administrative data.接受生物制剂治疗慢性炎症性疾病患者的严重感染风险:行政数据的效用
J Adv Res. 2018 Sep 19;15:87-93. doi: 10.1016/j.jare.2018.09.003. eCollection 2019 Jan.